Mesoblast Limited has successfully completed a fully underwritten institutional placement to raise A$52.5 million.
The proceeds will be used to strengthen Mesoblast’s balance sheet and support its ongoing clinical trials and commercial manufacturing requirements.
ASIC relief to use the ‘cleansing notice’ regime was required as Mesoblast had been suspended for more than five trading days in the past 12 months.
MinterEllison has advised Mesoblast on the capital raising, with a team led by partner Bart Oude-Vrielink (picture), with special counsel Sudharshan Senathirajah and Renee Doyle, and lawyer Sarah Soon.
Law Firms: Minter Ellison;
Clients: Mesoblast Ltd;